Dempze Nancy E Vertex Pharmaceuticals Inc Transaction History
Dempze Nancy E
- $162 Million
- Q3 2024
A detailed history of Dempze Nancy E transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Dempze Nancy E holds 4,869 shares of VRTX stock, worth $2.36 Million. This represents 1.4% of its overall portfolio holdings.
Number of Shares
4,869
Previous 2,583
88.5%
Holding current value
$2.36 Million
Previous $1.21 Million
87.11%
% of portfolio
1.4%
Previous 0.93%
Shares
3 transactions
Others Institutions Holding VRTX
# of Institutions
1,728Shares Held
225MCall Options Held
1.21MPut Options Held
1.44M-
Capital World Investors Los Angeles, CA26.8MShares$13 Billion1.99% of portfolio
-
Vanguard Group Inc Valley Forge, PA23.2MShares$11.2 Billion0.2% of portfolio
-
Black Rock Inc. New York, NY21.3MShares$10.3 Billion0.23% of portfolio
-
State Street Corp Boston, MA11.8MShares$5.72 Billion0.23% of portfolio
-
Capital Research Global Investors Los Angeles, CA9MShares$4.36 Billion0.9% of portfolio
About VERTEX PHARMACEUTICALS INC
- Ticker VRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 256,691,008
- Market Cap $124B
- Description
- Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...